RecruitingNot ApplicableNCT06739759
Ovarian Hyperstimulation Syndrome Prevention
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
Sponsor
Aljazeera Hospital
Enrollment
300 participants
Start Date
Nov 17, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Ovarian hyperstimulation is a very hazardous complication of ICSI
Eligibility
Sex: FEMALEMin Age: 19 YearsMax Age: 42 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at ways to prevent ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovary syndrome (PCOS) who are undergoing fertility treatment (ICSI — a type of IVF). OHSS is a potentially serious complication where the ovaries overreact to fertility medications, causing bloating, pain, and in severe cases, fluid buildup.
**You may be eligible if...**
- You have been diagnosed with polycystic ovary syndrome (PCOS)
- You are undergoing an ICSI (intracytoplasmic sperm injection) fertility procedure
**You may NOT be eligible if...**
- You do not have PCOS
- You are not undergoing ICSI fertility treatment
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAntagonist protocol for IVF
antagonist protocol with triggering by Decapeptyl
DRUGModified Agonist protocol for IVF with additive treatments as HCQ
giving additive drugs to agonist protocolas HCQ
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06739759